Singapore: Da Vita Kidney Care recently announced the appointment of Mr Rehan Khan as the president of the company's kidney care business in Asia Pacific. Apart from leadership roles at AstraZeneca, Accenture and Venture Media Mr Khan recently served as the managing director of Abbott India.

DaVita delivers its life-sustaining kidney care services to patients in 64 centers across the Asia Pacific region, in both urban and remote, rural areas. Chronic kidney disease (CKD) is a major health problem for the underdeveloped countries of southeast Asia, home to more than 2 billion people.

It is estimated that 10 percent of the world's population has chronic kidney disease (CKD), and many do not know it because the symptoms go unnoticed until the disease has progressed to full renal failure.

Mr Atul Mathur, executive vice president of global operations at DaVita HealthCare Partners, said, "Mr Khan is a strong leader and will help grow our network of dialysis centers across Asia Pacific. He brings to the team over 20 years of diverse experience in the healthcare industry across the US, Europe and Asia."

With a view to expad its operations in the Asia Pacific region, DaVita recently announced collaboration with Khazanah Nasional Berhad, the strategic investment fund of the Government of Malaysia, and Mitsui & Co., one of the most diversified and comprehensive trading, investment and service companies in the world, giving the company great financial resources and market knowledge.

"Atul and I look forward to having Mr Khan as a key member of our operating team," said Mr Dennis Kogod, chief executive officer of DaVita International. "This is a very exciting time in Asia Pacific, especially given the recent announcement of our new joint venture with Khazanah and Mitsui."

"I am truly looking forward to working with my new DaVita teammates to drive growth in the Asia-Pacific region," said Mr Khan. "There is a powerful opportunity to provide access to high-quality kidney care to patients who are in dire need."